Granahan Investment Management - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$9,279,297
+22.9%
534,214
-0.4%
0.33%
+42.7%
Q2 2023$7,552,920
+22.1%
536,429
-6.7%
0.23%
+23.4%
Q1 2023$6,186,354
-18.1%
574,940
+14.0%
0.19%
-18.6%
Q4 2022$7,552,811
+6.5%
504,193
-8.7%
0.23%
-0.4%
Q3 2022$7,092,000
+74.3%
552,350
+31.5%
0.23%
+66.9%
Q2 2022$4,070,000
-44.8%
419,995
-43.4%
0.14%
-24.0%
Q1 2022$7,377,000
+4.5%
742,158
+23.8%
0.18%
+26.2%
Q4 2021$7,056,000
+52.7%
599,522
+47.7%
0.14%
+64.8%
Q3 2021$4,622,000405,8340.09%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders